CHARLENE ZABLOTNEY: Open Payments
NPI 1215177647 · WILKES BARRE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,068 in 43 payments from 14 companies in 2025. Trend: 2023 $816 · 2024 $225 · 2025 $1,068
Food & beverage: $1,068
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $296 |
| Verona Pharma, Inc. | 8 | $213 |
| Grifols USA, LLC | 4 | $183 |
| GlaxoSmithKline, LLC. | 6 | $107 |
| Insmed, Inc. | 4 | $59 |
| Actelion Pharmaceuticals US, Inc. | 2 | $41 |
| GENZYME CORPORATION | 2 | $37 |
| Axsome Therapeutics, Inc. | 1 | $26 |
| Phathom Pharmaceuticals, Inc. | 1 | $21 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $19 |
Products named: Ohtuvayre, TEZSPIRE, Prolastin-C Liquid, FASENRA, Arikayce, DUPIXENT, NUCALA, TRELEGY ELLIPTA.
Industry payments across PA — which companies pay providers there.
